Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-10-15

Clinical Trial Update: Diarrhea and Bivalent Oral Polio Vaccine Immunity [NA]

View source ↗

Summary

A completed trial assessed seroimmunity to poliovirus and incidence of diarrhea following administration of the bivalent oral polio vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bivalent Oral Polio Vaccine (types 1 and 3) (Oral poliovirus vaccine (live, attenuated))

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Seroimmunity, Diarrhea | NA | Status: COMPLETED